Wegovy is the first GLP-1 approved for weight loss, but there are several new GLP-1 drugs in development. One of the most ...

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...

A DAILY weight-loss pill could be approved in Britain within days, it has been reported. A pill version of the weight loss ...

Pfizer presented data ​on Saturday that showed a monthly dose of an experimental obesity drug it acquired through ‌its ...

Pfizer executives said most patients experienced few or mild side effects, with gastrointestinal events largely limited ​to ...

Doctors say Wegovy was designed to support long-term weight management, not overnight transformations.

Investors appear to have left Novo Nordisk behind as they focus on Eli Lilly; that could be a mistake.

The same drug that is helping patients manage diabetes and reduce their risk of serious complications from chronic conditions ...

Doctors say preserving strength and muscle mass is becoming one of the biggest concerns during rapid weight-loss treatment.

Most illegally sourced weight-loss medicines seized this year bear “no resemblance” to authorised versions, sparking fears ...

Zealand Pharma said on Friday its experimental obesity drug, co-developed with Swiss partner Roche, showed encouraging tolerability in a mid-stage trial, bolstering its push to ​take on market leaders ...